Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01188252
Show Display Options
Rank Status Study
1 Active, not recruiting Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies
Condition: Neoplasms
Intervention: Drug: Roniciclib (BAY1000394)

Indicates status has not been verified in more than two years